Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CEL | P19835 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PTPRC | P08575 | 1/20 | 0.30 |
| ▸ | PTPRF | P10586 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15437891 | 0.88 | MAPT (0.41) | MAPTDAOMAOAMAOBESR2 | |
| SCHEMBL11688485 | 0.83 | ESR2 (0.42) | MAPTESR2 | |
| SCHEMBL11417033 | 0.82 | MAPT (0.40) | MAPTMAOAMAOBESR2 | |
| SCHEMBL3975744 | 0.81 | DAO (0.34) | MAPTDAOMAOAMAOBCEL | |
| SCHEMBL11593529 | 0.79 | MAPT (0.44) | MAPTESR2 | |
| SCHEMBL1051743 | 0.72 | MAPT (0.35) | MAPTDAO | |
| SCHEMBL1780082 | 0.72 | MAPT (0.35) | MAPTDAO | |
| SCHEMBL4574060 | 0.72 | TRIM24 (0.42) | MAPTDAOESR2KMT2A | |
| SCHEMBL2353111 | 0.71 | — | — | |
| SCHEMBL1022576 | 0.70 | TLR4 (0.52) | MAPTDAOMAOAMAOBCEL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110009560-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-01-13 | — | — | US | disclosed |
| EP-2265564-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | Dow Global Technologies Inc. (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2009114466-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-09-17 | — | — | WO | disclosed |
| EP-0612783-B1 | Cyanate resin composition and copper-clad laminate | SUMITOMO CHEMICAL CO (JP) | 1999-05-06 | — | — | EP | disclosed |
| US-5563237-A | INCLUDES A BISMALEIMIDE HARDENER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-10-08 | — | — | US | disclosed |
| EP-0612783-A1 | Cyanate resin composition and copper-clad laminate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009560-A1 | ETHYLENICALLY UNSATURATED MONOMERS COMPRISING ALIPHATIC AND AROMATIC MOIETIES | ELOB, ELOC, ELP1 | MAPT 486/4885DAO 4381/4885MAOA 4320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.